Cannara Biotech Inc.Cannara Biotech Inc.Cannara Biotech Inc.

Cannara Biotech Inc.

No trades

Fundamentals and stats

Top segments and regional performance

Last year, the company generated ‪77.74 M‬ USD, the most of which — ‪74.95 M‬ USD — came from its top-performing segment, Cannabis, compared to ‪57.50 M‬ USD the previous year. The greatest contribution came from Canada, which accounted for ‪74.95 M‬ USD last year, with ‪57.50 M‬ USD the year before.

By source
By country